Section Arrow
Quote
SXTC.NASDAQ
- China Sxt Pharmaceuticals Inc
Quotes are at least 15-min delayed:2026/08/19 08:29 EDT
Pre Market
Last
 4.95
-0.18 (-3.51%)
Bid
4.94
Ask
4.96
High 5.3233 
Low 4.72 
Volume 73.66K 
Regular Hours (Closed)
Last
 5.13
+1.38 (+36.80%)
Day High 
5.55 
Prev. Close
3.75 
1-M High
228 
Volume 
13.23M 
Bid
4.94
Ask
4.96
Day Low
4.2 
Open
4.79 
1-M Low
3.1 
Market Cap 
2.00M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.49 
20-SMA 24.2 
50-SMA 120.02 
52-W High 83,758.8 
52-W Low 2.293333 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-730.40/--
Enterprise Value
2.70M
Balance Sheet
Book Value Per Share
55.63
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.14M
Operating Revenue Per Share
3.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMLXAmylyx Pharmaceuticals35.11+13.68+63.84%-- 
Pre Market 36.61 +1.5 +4.27%
SXTCChina Sxt Pharmaceuticals Inc5.13+1.38+36.80%-- 
Pre Market 4.95 -0.18 -3.51%
HLNHaleon plc9.72+0.14+1.46%19.54PE
Pre Market 9.7588 +0.0388 +0.40%
VTRSViatris16.17-0.06-0.37%-- 
Pre Market 16.4527 +0.2827 +1.75%
HIMSHims & Hers Health27.39-1.22-4.26%-- 
Pre Market 27.19 -0.2 -0.73%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.